[Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a]

Nihon Naika Gakkai Zasshi. 2005 Dec 10;94(12):2600-2. doi: 10.2169/naika.94.2600.

[Article in Japanese]

Authors

Yukiko Maede¹, Keiichi Morishita, Kunihiro Iwamura, Yukiko Takayama, Yuriko Tsukada, Maiko Kishino, Takeshi Shimizu, Shouzou Matsushima, Tatsuji Komatsu, Youko Kasagi

Affiliation

¹ Department of clinical research, National Hospital Organization Yokohama Medical Center, Yokohama.

PMID: 16419601
DOI: 10.2169/naika.94.2600

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use*
Early Diagnosis
Female
Graves Disease / chemically induced*
Graves Disease / diagnosis
Graves Disease / drug therapy
Hepatitis C, Chronic / drug therapy*
Humans
Interferon alpha-2
Interferon-alpha / administration & dosage
Interferon-alpha / adverse effects*
Methimazole / therapeutic use
Polyethylene Glycols / administration & dosage
Polyethylene Glycols / adverse effects*
Recombinant Proteins
Treatment Outcome

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Methimazole
peginterferon alfa-2a